Next Article in Journal
Post Approval Human Papillomavirus Vaccine Uptake Is Higher in Minorities Compared to Whites in Girls Presenting for Well-Child Care
Next Article in Special Issue
Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation
Previous Article in Journal
Sustaining Vaccine Confidence in the 21st Century
Vaccines 2013, 1(3), 225-249; doi:10.3390/vaccines1030225
Review

Vector Design for Improved DNA Vaccine Efficacy, Safety and Production

Received: 14 May 2013; in revised form: 12 June 2013 / Accepted: 18 June 2013 / Published: 25 June 2013
(This article belongs to the Special Issue DNA Vaccines)
View Full-Text   |   Download PDF [653 KB, updated 10 July 2013; original version uploaded 25 June 2013]   |   Browse Figures
Abstract: DNA vaccination is a disruptive technology that offers the promise of a new rapidly deployed vaccination platform to treat human and animal disease with gene-based materials. Innovations such as electroporation, needle free jet delivery and lipid-based carriers increase transgene expression and immunogenicity through more effective gene delivery. This review summarizes complementary vector design innovations that, when combined with leading delivery platforms, further enhance DNA vaccine performance. These next generation vectors also address potential safety issues such as antibiotic selection, and increase plasmid manufacturing quality and yield in exemplary fermentation production processes. Application of optimized constructs in combination with improved delivery platforms tangibly improves the prospect of successful application of DNA vaccination as prophylactic vaccines for diverse human infectious disease targets or as therapeutic vaccines for cancer and allergy.
Keywords: DNA vaccination; plasmid; antibiotic-free; non-viral; fermentation; immunization; adjuvant; innate immunity DNA vaccination; plasmid; antibiotic-free; non-viral; fermentation; immunization; adjuvant; innate immunity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Williams, J.A. Vector Design for Improved DNA Vaccine Efficacy, Safety and Production. Vaccines 2013, 1, 225-249.

AMA Style

Williams JA. Vector Design for Improved DNA Vaccine Efficacy, Safety and Production. Vaccines. 2013; 1(3):225-249.

Chicago/Turabian Style

Williams, James A. 2013. "Vector Design for Improved DNA Vaccine Efficacy, Safety and Production." Vaccines 1, no. 3: 225-249.


Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert